Email ID
Password
Scrip   
AstraZeneca and CRT to develop cancer metabolism targeted therapies
08 February 2010
Christopher Spillane

Cancer Research Technology (CRT) will collaborate with AstraZeneca to create a slate of new anticancer therapies over the next three years. CRT, the commercial and development arm of Cancer Research UK, will select the candidates for use in the field of cancer metabolism.

...



Please Login to read the full article.
EVENTS
11 March 2010
Cambridge, UK
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36